Compile Data Set for Download or QSAR
Report error Found 157 Enz. Inhib. hit(s) with all data for entry = 7013
TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166453(US9073853, 12)
Affinity DataIC50: 13nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166545(US9073853, 104)
Affinity DataIC50: 15nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166446(US9073853, 5)
Affinity DataIC50: 19nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166528(US9073853, 87)
Affinity DataIC50: 19nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166447(US9073853, 6)
Affinity DataIC50: 20nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166475(US9073853, 34)
Affinity DataIC50: 22nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166529(US9073853, 88)
Affinity DataIC50: 23nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166455(US9073853, 14)
Affinity DataIC50: 25nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166466(US9073853, 25)
Affinity DataIC50: 25nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166589(US9073853, 148)
Affinity DataIC50: 26nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166477(US9073853, 36)
Affinity DataIC50: 28nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166450(US9073853, 9)
Affinity DataIC50: 32nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166457(US9073853, 16)
Affinity DataIC50: 35nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166445(US9073853, 4)
Affinity DataIC50: 37nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166456(US9073853, 15)
Affinity DataIC50: 37nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166448(US9073853, 7)
Affinity DataIC50: 38nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166474(US9073853, 33)
Affinity DataIC50: 42nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166458(US9073853, 17)
Affinity DataIC50: 44nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166516(US9073853, 75)
Affinity DataIC50: 45nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166517(US9073853, 76)
Affinity DataIC50: 45nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166523(US9073853, 82)
Affinity DataIC50: 46nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166530(US9073853, 89)
Affinity DataIC50: 52nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166471(US9073853, 30)
Affinity DataIC50: 53nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166546(US9073853, 105)
Affinity DataIC50: 53nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166460(US9073853, 19)
Affinity DataIC50: 55nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166510(US9073853, 69)
Affinity DataIC50: 56nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166567(US9073853, 126)
Affinity DataIC50: 58nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166465(US9073853, 24)
Affinity DataIC50: 58nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166444(US9073853, 3)
Affinity DataIC50: 60nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166441(US9073853, 1)
Affinity DataIC50: 60nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166504(US9073853, 63)
Affinity DataIC50: 62nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166459(US9073853, 18)
Affinity DataIC50: 64nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166451(US9073853, 10)
Affinity DataIC50: 64nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166467(US9073853, 26)
Affinity DataIC50: 64nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166484(US9073853, 43)
Affinity DataIC50: 68nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166563(US9073853, 122)
Affinity DataIC50: 70nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166595(US9073853, 154)
Affinity DataIC50: 70nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166526(US9073853, 85)
Affinity DataIC50: 71nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166558(US9073853, 117)
Affinity DataIC50: 71nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166598(US9073853, 157)
Affinity DataIC50: 71nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166550(US9073853, 109)
Affinity DataIC50: 73nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166478(US9073853, 37)
Affinity DataIC50: 76nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166508(US9073853, 67)
Affinity DataIC50: 77nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166597(US9073853, 156)
Affinity DataIC50: 79nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166468(US9073853, 27)
Affinity DataIC50: 80nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166469(US9073853, 28)
Affinity DataIC50: 81nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166481(US9073853, 40)
Affinity DataIC50: 81nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166554(US9073853, 113)
Affinity DataIC50: 82nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166534(US9073853, 93)
Affinity DataIC50: 84nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetC-X-C chemokine receptor type 3(Human)
Sanofi

US Patent
LigandPNGBDBM166507(US9073853, 66)
Affinity DataIC50: 85nMAssay Description:Competition radioligand binding assays were performed to determine the in vitro potency of the newly synthesized, unlabeled test compounds to displac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

Displayed 1 to 50 (of 157 total ) | Next | Last >>
Jump to: